{"entities":{"Q9877":{"pageid":14038,"ns":120,"title":"Item:Q9877","lastrevid":205797,"modified":"2020-05-21T15:47:06Z","type":"item","id":"Q9877","labels":{"en":{"language":"en","value":"Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9877$54007D38-2D86-4470-9195-A5900F676FE9","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9877$237F2941-5E92-458E-A118-F9AC525BB8EA","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Cortes JE","type":"string"},"datatype":"string"},"type":"statement","id":"Q9877$7FD19B3B-A229-473C-B2AC-35D345734377","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1002/ajh.25238","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9877$069CC7D8-D1CC-4DBA-B097-9223793AB388","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"30074259","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9877$B5B9D8D4-F262-41E1-B11F-AA1973F26767","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2018-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9877$1F0E2DDD-BEA6-429B-AA08-2F4BB234F3E4","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Am. J. Hematol.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9877$39264141-4328-4167-AF8E-BBD1B3F82C4A","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"93","type":"string"},"datatype":"string"},"type":"statement","id":"Q9877$8DA8B8B8-F1CB-422A-8A4D-44056F0C45AB","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: phase 2 study results","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9877$A9AD3854-0610-4AA3-924E-B89984627B49","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"1301-1310","type":"string"},"datatype":"string"},"type":"statement","id":"Q9877$A42076F8-5B24-4F6E-B461-4BDB127489F2","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Cortes JE, et al. Am. J. Hematol. (2018) cited as Ref 614 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Cortes_JE,_et_al._Am._J._Hematol._(2018)_cited_as_Ref_614_in_DOI:_10.1038/s41392-020-0110-5"}}}}}